Tag: Tralokinumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Tralokinumab

Go or no go? The FDA plays hardball

Added to Collection on: 2021-03-30 12:53:19

Tags for this article:

Drugs
Health sciences
Health care
Monoclonal antibodies
Breakthrough therapy
Antineoplastic drugs
Dupilumab
Sanofi
Cancer immunotherapy
Regeneron Pharmaceuticals
Tofacitinib
Tralokinumab

Click the tags to see associated articles and topics

View Article Details
FDA CRL Hurdle for LEO Pharma on Tralokinumab

Added to Collection on: 2021-04-30 18:56:15

Tags for this article:

Monoclonal antibodies
Clinical medicine
Medicine
Medical specialties
Type I hypersensitivity
Tralokinumab
Dupilumab
Atopic dermatitis
Dermatitis
Regeneron Pharmaceuticals
Eczema Area and Severity Index
Sanofi

Click the tags to see associated articles and topics

View Article Details
AbbVie's Rinvoq needs steep discount in eczema, cost watchdog ICER says

Added to Collection on: 2021-05-14 15:45:00

Tags for this article:

Health
Drugs
Monoclonal antibodies
Institute for Clinical and Economic Review
Sanofi
Dupilumab
Regeneron Pharmaceuticals
Tralokinumab
ICER
Atopic dermatitis
Janus kinase inhibitor
Cost-effectiveness analysis

Click the tags to see associated articles and topics

View Article Details
LEO Pharma announces European Commission approval of Adtralza® (tralokinumab) as the first ...

Added to Collection on: 2021-06-22 06:00:00

Tags for this article:

Monoclonal antibodies
Type I hypersensitivity
Steroids
Tralokinumab
Immunology
Medical specialties
Atopic dermatitis
Dermatitis
Atopy
Sodium hypochlorite washes
Dupilumab
leo pharma a/s

Click the tags to see associated articles and topics

View Article Details
Tralokinumab Linked to Ocular Diseases in Patients with Atopic Dermatitis - Dermatology Times

Added to Collection on: 2021-10-26 14:52:40

Tags for this article:

Medical specialties
Immunology
Clinical medicine
Monoclonal antibodies
Type I hypersensitivity
Tralokinumab
Dupilumab
Atopic dermatitis
Conjunctivitis
Dermatitis
Atopy
Allergic conjunctivitis

Click the tags to see associated articles and topics

View Article Details
Leo Pharma's FDA nod adds a challenger to Dupixent's dominance in eczema - MedCity News

Added to Collection on: 2021-12-28 17:18:49

Tags for this article:

Health sciences
Life Sciences
Health care
Monoclonal antibodies
Type I hypersensitivity
Tralokinumab
Dupilumab
Atopic dermatitis
Dermatitis
Regeneron Pharmaceuticals
Sanofi
Lebrikizumab
United States
Leo Pharma

Click the tags to see associated articles and topics

View Article Details
Managing Atopic Dermatitis with Lebrikizumab | CCID - Dove Medical Press

Added to Collection on: 2022-06-07 13:55:25

Tags for this article:

Monoclonal antibodies
Medical specialties
Organ systems
Immunology
Lebrikizumab
Dupilumab
Atopic dermatitis
Upadacitinib
Immunoglobulin E
Idiopathic pulmonary fibrosis
Dermatitis
Tralokinumab

Click the tags to see associated articles and topics

View Article Details
JAK Inhibitors May Help Control Symptoms in Moderate-to-Severe AD - Physician's Weekly

Added to Collection on: 2022-08-30 12:31:59

Tags for this article:

Monoclonal antibodies
RTT
Drugs
Medical specialties
Immunology
Breakthrough therapy
Dupilumab
Sanofi
Autoimmune diseases
Atopic dermatitis
Tralokinumab
Upadacitinib

Click the tags to see associated articles and topics

View Article Details
LEO Pharma presents new AdbryTM (tralokinumab-ldrm) safety data in moderate-to-severe ...

Added to Collection on: 2022-09-08 18:25:34

Tags for this article:

Corticosteroids
RTT
Medical specialties
Monoclonal antibodies
Immunology
Chemical compounds
Tralokinumab
Atopic dermatitis
Dermatitis
Topical steroid
Sodium hypochlorite washes
Dupilumab
leo pharma a/s

Click the tags to see associated articles and topics

View Article Details